Ticker > Company >

Jupiter Life Line share price

Jupiter Life Line Hospitals Ltd.

NSE: JLHL BSE: 543980 SECTOR: Hospital & Healthcare Services  38k   27   14

1,452.20
-16.20 (-1.10%)
BSE: 20 Jun 04:01 PM

Price Summary

Today's High

₹ 1,519.55

Today's Low

₹ 1,442.10

52 Week High

₹ 1,759

52 Week Low

₹ 1,177.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9,521.50 Cr.

Enterprise Value

9,108.74 Cr.

No. of Shares

6.56 Cr.

P/E

51.55

P/B

6.69

Face Value

₹ 10

Div. Yield

0.07 %

Book Value (TTM)

₹  216.96

CASH

487.76 Cr.

DEBT

75 Cr.

Promoter Holding

40.91 %

EPS (TTM)

₹  28.17

Sales Growth

15.90%

ROE

13.85 %

ROCE

18.59%

Profit Growth

21.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.9%
3 Year17.27%
5 Year18.02%

Profit Growth

1 Year19.96%
3 Year29.49%
5 Year44.06%

ROE%

1 Year13.85%
3 Year19.56%
5 Year18.93%

ROCE %

1 Year18.59%
3 Year22.38%
5 Year19.86%

Debt/Equity

0.05

Price to Cash Flow

43.30

Interest Cover Ratio

29.63

CFO/PAT (5 Yr. Avg.)

1.41

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 40.91 0.00
Dec 2024 40.91 0.00
Sep 2024 40.91 0.00
Jun 2024 40.91 0.00
Mar 2024 40.91 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.69% for the Past 3 years.
  • The company has shown a good revenue growth of 17.27% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 22.38% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 29.63.
  • The Company has been maintaining an effective average operating margins of 23.00% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -106.38 days.
  • Company has a healthy liquidity position with current ratio of 5.48.
  • The company has a good cash flow management; CFO/PAT stands at 1.41.

 Limitations

  • The company is trading at a high PE of 51.55.
  • The company is trading at a high EV/EBITDA of 30.99.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 246.12 239.41 273.10 269.13 273.91
Total Expenditure 188.93 183.73 203.66 201.69 201.71
Operating Profit 57.19 55.68 69.45 67.44 72.21
Other Income 7.94 8.24 9.26 8.13 6.95
Interest 0.93 0.95 1 2.65 4
Depreciation 7.47 7.98 10.41 10.64 13.38
Exceptional Items 2.28 0 0 0 0
Profit Before Tax 59.01 54.99 67.29 62.28 61.78
Tax 15.87 14.34 17 12.97 17.33
Profit After Tax 43.15 40.65 50.30 49.31 44.45
Adjusted EPS (Rs) 6.58 6.20 7.67 7.52 6.78

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 461.10 657.28 787.32 914.57 1,060
Total Expenditure 393.58 498.43 583.29 687.26 790.78
Operating Profit 67.51 158.85 204.03 227.31 269.22
Other Income 5.59 3.75 13.30 25.69 28.14
Interest 28.17 29.23 27.71 18.66 8.61
Depreciation 27.38 27.66 28.61 30.52 42.41
Exceptional Items 0 0 -2.13 0 0
Profit Before Tax 17.55 105.71 158.88 203.82 246.34
Tax 0.96 21.04 51.67 51.87 61.64
Net Profit 16.59 84.67 107.21 153.26 183.84
Adjusted EPS (Rs.) 3.26 16.65 18.97 23.18 28.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 50.87 50.87 56.52 65.57 65.57
Total Reserves 202.47 278.01 408.51 1,179.69 1,356.98
Borrowings 258.15 297.88 294.69 0 74.25
Other N/C liabilities 22.56 24.70 25 27.04 91.98
Current liabilities 81.12 103.30 100.62 88.30 121.57
Total Liabilities 615.17 754.75 885.34 1,360.60 1,710.34
Assets
Net Block 426.42 464.58 476.47 477.32 713.20
Capital WIP 13.33 13.86 16.24 61.10 162.56
Intangible WIP 0 0 0 0 0
Investments 58.03 68.13 94.04 94.03 94.03
Loans & Advances 8.33 29.07 85.37 326.97 73.39
Other N/C Assets 0 2.78 16.37 17.45 1.28
Current Assets 109.06 176.32 196.84 383.72 665.88
Total Assets 615.17 754.75 885.34 1,360.60 1,710.34
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 17.55 105.71 158.88 203.82 246.34
Adjustment 54.41 53.95 48.65 24.97 23.98
Changes in Assets & Liabilities 50.98 -8.69 9.80 -69.32 11.94
Tax Paid -9.79 -8.62 -33.30 -49.68 -62.39
Operating Cash Flow 113.15 142.35 184.03 109.79 219.88
Investing Cash Flow -78.22 -68.92 -129.66 -238.04 -173.29
Financing Cash Flow -23.43 10.28 -23.23 121.88 301.84
Net Cash Flow 11.50 83.70 31.15 -6.36 348.43

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 40.91 40.91 40.91 40.91 40.91
ajay p thakker 20.74 20.74 20.74 20.74 20.74
ajay p thakker huf 0.01 0.01 0.01 0.01 0.01
ankit thakker 6.67 6.67 6.67 6.67 6.67
devang vasantlal gandhi 0.63 0.63 0.63 0.63 0.63
kirtika ajay thakker 2.03 2.03 2.03 2.03 2.03
neeta devang gandhi 2.10 2.10 2.10 2.10 2.10
nikita ankit thakker 0.02 0.02 0.02 0.02 0.02
western medical solutions... 8.70 8.70 8.70 8.70 8.70
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 59.09 59.09 59.09 59.09 59.09
a s arvind 1.48 1.48 1.21 1.21 1.21
brijesh ramakant tibrewal... 1.87 1.82 1.82 1.82 1.82
darshana mitesh chothani 1.97 1.93 - 1.03 1.11
dr navin ramji davda 2.01 2.01 2.00 2.00 2.00
goldman sachs funds - gol... 1.50 1.51 2.25 2.34 2.34
j m financial and investm... 1.91 1.91 1.91 1.91 1.91
jm financial products lim... 3.42 3.42 3.42 3.42 3.42
kamini arvind rao 3.00 3.00 3.27 - 3.27
mahesh ramakant tibrewala... 1.87 1.82 1.82 1.82 1.82
mihir wire industries pvt... 2.15 2.15 2.15 2.15 2.15
nitin manilal thakker 3.39 3.39 2.17 2.17 1.86
rajesh hiralal vora 1.91 1.22 1.22 1.22 1.22
ramakant jagdish tibrewal... 1.87 1.87 1.87 1.87 1.87
sbi healthcare opportunit... 8.09 8.07 8.19 7.32 7.29
snk investments private l... - - 1.39 1.39 1.39
sushma ramakant tibrewala... 1.87 1.23 1.23 1.22 1.22
custody bank of japan, lt... - 1.38 1.53 1.40 -
kamini a rao - - - 3.27 -
axis mutual fund trustee ... - 1.19 1.03 - -
persepolis investment com... 1.39 1.39 - - -
axis mutual fund trustee ... 1.19 - - - -

Annual Reports

Title Link
No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
Credit ICRA
Credit CARE
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
Concall Q4FY25
Concall Q4FY24
Concall Q3FY24
Concall Q2FY24
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY25
Presentation Q1FY24

Company News

Jupiter Life Line Stock Price Analysis and Quick Research Report. Is Jupiter Life Line an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Jupiter Life Line and its performance over the period of time. Jupiter Life Line stock price today is Rs 1,458.80.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Jupiter Life Line cash from the operating activity was Rs 219.88 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Jupiter Life Line has a Debt to Equity ratio of 0.05 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Jupiter Life Line , the EPS growth was 21.55 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Jupiter Life Line has OPM of 25.40 % which is a good sign for profitability.
     
  • ROE: Jupiter Life Line have a average ROE of 13.85 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Jupiter Life Line is Rs 1,458.80. One can use valuation calculators of ticker to know if Jupiter Life Line share price is undervalued or overvalued.
Last Updated on:
Brief about Jupiter Life Line
X